Event Report 2021
-
Public Affairs Committee
JPMA Media Forum" Held
Vaccination in the Era of With Corona - Learning from Pandemics -
International Affairs Committee
The 5th Japan-India Symposium on Regulation of Medical Products
Proactive Communication for the Development of Japan-India Cooperation Scheme in the Pharmaceutical Field -
International Affairs Committee
The "Regular Meeting with the Association of the British Pharmaceutical Industry (ABPI)" was held.
-
Biopharmaceutical Committee
CMC Strategy Forum Japan 2021" will be held
-
International Affairs Committee
Held "Regular Meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA)
-
Secretariat
The 20th JPMA Forum" held
-
Patient Cooperation Committee
The 39th JPMA Patient Group Seminar" was held.
Let's Think Together, Future Drug Development (Clinical Trials) - Let's Open the Door to the Future Together -
ICH Project
ICH Vancouver Meeting to be Held via Web Conference
-
Drug Evaluation Committee
The 139th Assembly of the Drug Evaluation Committee
Looking Back on the New Coronavirus - Sharing Best Practices and Resolving Domestic Issues -
International Affairs Committee
Special Program at the 8th Nikkei-FT Conference on Infectious Diseases
Preparing for Emerging and Re-emerging Infectious Diseases including Drug Resistant Bacteria - Unknown Threats, National Response -
The Office of Pharmaceutical Industry Research
Workshop on the Value of Drugs: Considering the Value of Drugs and Their Evaluation from the Perspective of the Public and Patients," hosted by the Policy Research Institute
-
Public Affairs Committee
Held the 36th Public Relations Seminar.
From Strategic PR to Narrative Company: New PR and Companies after the New Normal -
International Affairs Committee
The 9th Taiwan-Japan Pharmaceutical Exchange Conference" was held.
-
International Affairs Committee
The "Regular Meeting with the French Association of the Pharmaceutical Industry (LEEM)
-
Biopharmaceutical Committee
Report on "BioJapan 2021" and its participation
Biopharmaceutical Committee Seminar -
Pharmaceutical Industrial Policy Committee
Holding of "Pharmaceutical Industry Vision 2021 Briefing Session
-
Code Compliance Committee
The "2021 Meeting of Code Administration Managers and Practitioners" was held
-
Regulatory Affairs Committee
The 11th Annual Meeting of the Regulatory Science Society of Japan held
Regulatory Science to accelerate social implementation -
Pharmaceutical Industrial Policy Committee
Guideline Workshops on the Revised Tax Credit System for Special Research Expenses" held
-
Quality & Technology Committee
The 48th GMP Case Study Workshop in FY2021
-
ICH Project, International Affairs Committee
Japan-China ICH Joint Symposium" Held
-
ICH Project
ICH Incheon Conference to be Held via Web Conference
-
International Affairs Committee
PMDA and JPMA Jointly Host COVID-19 Session at DIA China 2021
-
Public Affairs Committee
JPMA Presidents Press Conference
New President Yasushi Okada Delivers his Message -
International Affairs Committee
The "Regular Meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA)" was held.
-
Public Affairs Committee
JPMA/PhRMA/EFPIA Joint Press Conference Held
Recommendations for the formulation of the "Framework Policy" and "Vision for the Pharmaceutical Industry -
Public Affairs Committee
JPMA/PhRMA/EFPIA Joint Press Conference
Recommendations for the formulation of the "Framework Policy" and "Vision for the Pharmaceutical Industry -
International Affairs Committee
JPMA Media Forum" Held
The need for new antimicrobial agents against Antimicrobial Resistance (AMR) reaffirmed by the new coronavirus pandemic -
Regulatory Affairs Committee
Joint Assembly of Drug Evaluation Committee and Regulatory Affairs Committee for 2021" was held
-
APAC Project
Held the 10th APAC (Asia-Pacific Association of Pharmaceutical Manufacturers and Associations) Conference
-Mission: Delivering Innovative Medicines to the People of Asia Quickly
The theme is "Overcoming COVID-19 and Toward a Decade of New Innovation Challenges in Asia -
Public Affairs Committee
JPMA Presidents Press Conference
Necessity of Industrial Policy in the JPMA Industry" and "JPMA Policy Proposal 2021 -
Pharmaceutical Industrial Policy Committee
JPMA Media Forum" Held
Reconsidering the Diverse Values of Pharmaceuticals: What Contributions to Society are Expected from Pharmaceuticals? -
Review Board of Ethical Drug Product Information Brochure
Workshop for Persons Responsible for Product Information Overview and Management and for Practical Responsibility in FY2020" was held.
-
Code Compliance Committee
Held the "FY2020 Meeting of Compliance Managers and Managers in Charge of Compliance Management
-
Public Affairs Committee
Held the 32nd JPMA Policy Seminar
Contribution of Innovation for Patients: Drug Discovery in the With COVID-19 Era -
Public Affairs Committee
Held the 32nd JPMA Policy Seminar
Contribution of Innovation for Patients: Drug Discovery in the With COVID-19 Era -
Intellectual Property Committee
Held the "2021 Life Science IP Forum
Theme is "How to handle IP rights in pandemic response measures including COVID-19" -
Public Affairs Committee
JPMA Media Forum" Held
What is a Vaccine? -Learning about vaccines once again in the Corona Disaster -
Public Affairs Committee
JPMA special program: TV-Iwate "Oraho no Kenko - Protecting Oraho's Health with Pharmaceuticals" (TV-Iwate) Oraho's Health Protected by Pharmaceuticals: Ten Years after the Earthquake and the Need for Countermeasures to Combat Infectious Diseases
*No view of 2021 is included in the program. -
International Affairs Committee
Exchange of views with the International Atomic Energy Agency (IAEA) and the Permanent Mission of Japan to the International Organizations in Vienna on various issues in the health sector
-
International Affairs Committee
The 7th Japan-Thailand Joint Symposium" was held
-
Public Affairs Committee
Medical Information Program "Iroshin Yakushin Yume no Meditemple 2021 Special" is now being broadcast by popular demand!